• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用作乳腺癌转移分类器的主调控因子。

Master regulators used as breast cancer metastasis classifier.

作者信息

Lim Wei Keat, Lyashenko Eugenia, Califano Andrea

机构信息

Center for Computational Biology and Bioinformatics, Department of Biomedical Informatics, Columbia University, 1130 Saint Nicholas Avenue, New York, NY 10032, USA.

出版信息

Pac Symp Biocomput. 2009:504-15.

PMID:19209726
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2740937/
Abstract

Computational identification of prognostic biomarkers capable of withstanding follow-up validation efforts is still an open challenge in cancer research. For instance, several gene expression profiles analysis methods have been developed to identify gene signatures that can classify cancer sub-phenotypes associated with poor prognosis. However, signatures originating from independent studies show only minimal overlap and perform poorly when classifying datasets other than the ones they were generated from. In this paper, we propose a computational systems biology approach that can infer robust prognostic markers by identifying upstream Master Regulators, causally related to the presentation of the phenotype of interest. Such a strategy effectively extends and complements other existing methods and may help further elucidate the molecular mechanisms of the observed pathophysiological phenotype. Results show that inferred regulators substantially outperform canonical gene signatures both on the original dataset and across distinct datasets.

摘要

在癌症研究中,通过计算识别能够经受住后续验证的预后生物标志物仍然是一个悬而未决的挑战。例如,已经开发了几种基因表达谱分析方法来识别可以对与不良预后相关的癌症亚表型进行分类的基因特征。然而,来自独立研究的特征仅显示出最小的重叠,并且在对除了它们所生成的数据集之外的其他数据集进行分类时表现不佳。在本文中,我们提出了一种计算系统生物学方法,该方法可以通过识别与感兴趣的表型呈现因果相关的上游主调节因子来推断稳健的预后标志物。这种策略有效地扩展和补充了其他现有方法,并可能有助于进一步阐明观察到的病理生理表型的分子机制。结果表明,推断出的调节因子在原始数据集和不同数据集上都大大优于经典基因特征。

相似文献

1
Master regulators used as breast cancer metastasis classifier.用作乳腺癌转移分类器的主调控因子。
Pac Symp Biocomput. 2009:504-15.
2
Mixture classification model based on clinical markers for breast cancer prognosis.基于临床标志物的乳腺癌预后混合分类模型。
Artif Intell Med. 2010 Feb-Mar;48(2-3):129-37. doi: 10.1016/j.artmed.2009.07.008. Epub 2009 Dec 14.
3
Identification of upstream regulators for prognostic expression signature genes in colorectal cancer.结直肠癌预后表达特征基因上游调控因子的鉴定
BMC Syst Biol. 2013 Sep 4;7:86. doi: 10.1186/1752-0509-7-86.
4
An ensemble machine learning approach to predict survival in breast cancer.一种用于预测乳腺癌生存率的集成机器学习方法。
Int J Comput Biol Drug Des. 2008;1(3):275-94. doi: 10.1504/ijcbdd.2008.021422.
5
Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer.系统生物学分析揭示NFAT5是炎性乳腺癌的一种新型生物标志物和主要调节因子。
J Transl Med. 2015 May 1;13:138. doi: 10.1186/s12967-015-0492-2.
6
Meta-analysis of breast cancer microarray studies in conjunction with conserved cis-elements suggest patterns for coordinate regulation.结合保守顺式元件对乳腺癌微阵列研究进行的荟萃分析揭示了协同调控模式。
BMC Bioinformatics. 2008 Jan 28;9:63. doi: 10.1186/1471-2105-9-63.
7
Fuzzy logic selection as a new reliable tool to identify molecular grade signatures in breast cancer--the INNODIAG study.模糊逻辑选择作为识别乳腺癌分子分级特征的一种新型可靠工具——INNODIAG研究
BMC Med Genomics. 2015 Feb 7;8:3. doi: 10.1186/s12920-015-0077-1.
8
MiSTIC, an integrated platform for the analysis of heterogeneity in large tumour transcriptome datasets.MiSTIC,一个用于分析大型肿瘤转录组数据集异质性的综合平台。
Nucleic Acids Res. 2017 Jul 27;45(13):e122. doi: 10.1093/nar/gkx338.
9
Identifying cancer biomarkers by network-constrained support vector machines.通过网络约束支持向量机识别癌症生物标志物。
BMC Syst Biol. 2011 Oct 12;5:161. doi: 10.1186/1752-0509-5-161.
10
FREQUENT SUBGRAPH MINING OF PERSONALIZED SIGNALING PATHWAY NETWORKS GROUPS PATIENTS WITH FREQUENTLY DYSREGULATED DISEASE PATHWAYS AND PREDICTS PROGNOSIS.个性化信号通路网络的频繁子图挖掘对疾病通路频繁失调的患者进行分组并预测预后。
Pac Symp Biocomput. 2017;22:402-413. doi: 10.1142/9789813207813_0038.

引用本文的文献

1
Network analysis of master regulators associated with invasive phenotypes in multiple myeloma.与多发性骨髓瘤侵袭性表型相关的主调控因子的网络分析。
Front Cell Dev Biol. 2025 Jul 16;13:1586870. doi: 10.3389/fcell.2025.1586870. eCollection 2025.
2
Medulloblastoma's master regulators and their association with patients' risk.髓母细胞瘤的主要调控因子及其与患者风险的关联。
Sci Rep. 2025 May 10;15(1):16310. doi: 10.1038/s41598-025-00763-3.
3
scVAEDer: integrating deep diffusion models and variational autoencoders for single-cell transcriptomics analysis.scVAEDer:整合深度扩散模型和变分自编码器用于单细胞转录组学分析
Genome Biol. 2025 Mar 21;26(1):64. doi: 10.1186/s13059-025-03519-4.
4
Pancancer network analysis reveals key master regulators for cancer invasiveness.泛癌症网络分析揭示了癌症侵袭性的关键主调控因子。
J Transl Med. 2023 Aug 20;21(1):558. doi: 10.1186/s12967-023-04435-6.
5
Enrichment analysis of phenotypic data for drug repurposing in rare diseases.罕见病中药物再利用的表型数据富集分析。
Front Pharmacol. 2023 Jul 25;14:1128562. doi: 10.3389/fphar.2023.1128562. eCollection 2023.
6
massiveGST: A Mann-Whitney-Wilcoxon Gene-Set Test Tool That Gives Meaning to Gene-Set Enrichment Analysis.大规模GST:一种为基因集富集分析赋予意义的曼-惠特尼-威尔科克森基因集测试工具。
Entropy (Basel). 2022 May 23;24(5):739. doi: 10.3390/e24050739.
7
The regulatory landscape of retinoblastoma: a pathway analysis perspective.视网膜母细胞瘤的监管格局:从通路分析角度看
R Soc Open Sci. 2022 May 18;9(5):220031. doi: 10.1098/rsos.220031. eCollection 2022 May.
8
p53 Promotes Cytokine Expression in Melanoma to Regulate Drug Resistance and Migration.p53 促进黑色素瘤细胞因子表达以调控耐药性和迁移。
Cells. 2022 Jan 25;11(3):405. doi: 10.3390/cells11030405.
9
Integrative multi-omics identifies high risk multiple myeloma subgroup associated with significant DNA loss and dysregulated DNA repair and cell cycle pathways.综合多组学鉴定与显著 DNA 丢失和失调的 DNA 修复及细胞周期途径相关的多发性骨髓瘤高危亚组。
BMC Med Genomics. 2021 Dec 18;14(1):295. doi: 10.1186/s12920-021-01140-5.
10
Mechanism-Centric Approaches for Biomarker Detection and Precision Therapeutics in Cancer.癌症生物标志物检测与精准治疗的以机制为中心的方法
Front Genet. 2021 Aug 2;12:687813. doi: 10.3389/fgene.2021.687813. eCollection 2021.

本文引用的文献

1
A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas.一种用于预测B细胞淋巴瘤中癌基因和分子扰动靶点的系统生物学方法。
Mol Syst Biol. 2008;4:169. doi: 10.1038/msb.2008.2. Epub 2008 Feb 12.
2
Reverse engineering cellular networks.细胞网络的逆向工程
Nat Protoc. 2006;1(2):662-71. doi: 10.1038/nprot.2006.106.
3
NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth.NOTCH1直接调控c-MYC并激活促进白血病细胞生长的前馈环转录网络。
Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18261-6. doi: 10.1073/pnas.0606108103. Epub 2006 Nov 17.
4
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.前列腺癌中TMPRSS2与ETS转录因子基因的反复融合
Science. 2005 Oct 28;310(5748):644-8. doi: 10.1126/science.1117679.
5
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.基因集富集分析:一种基于知识的方法用于解读全基因组表达谱。
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50. doi: 10.1073/pnas.0506580102. Epub 2005 Sep 30.
6
Integrative analysis of the cancer transcriptome.癌症转录组的综合分析
Nat Genet. 2005 Jun;37 Suppl:S31-7. doi: 10.1038/ng1570.
7
Reverse engineering of regulatory networks in human B cells.人类B细胞中调控网络的逆向工程
Nat Genet. 2005 Apr;37(4):382-90. doi: 10.1038/ng1532. Epub 2005 Mar 20.
8
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.预测淋巴结阴性原发性乳腺癌远处转移的基因表达谱。
Lancet. 2005;365(9460):671-9. doi: 10.1016/S0140-6736(05)17947-1.
9
Prediction of cancer outcome with microarrays: a multiple random validation strategy.利用微阵列预测癌症预后:一种多重随机验证策略。
Lancet. 2005;365(9458):488-92. doi: 10.1016/S0140-6736(05)17866-0.
10
Outcome signature genes in breast cancer: is there a unique set?乳腺癌的预后特征基因:是否存在一组独特的基因?
Bioinformatics. 2005 Jan 15;21(2):171-8. doi: 10.1093/bioinformatics/bth469. Epub 2004 Aug 12.